Terug
Dagbereik
€ 11,64
€ 12,21
52-Weeksbereik
€ 8,81
€ 23,29
Volume
2.013.007
50D / 200D Gem.
€ 14,45
/
€ 15,45
Vorige Slotkoers
€ 12,15
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -12,4 | 0,3 |
| P/B | 49,4 | 2,9 |
| ROE % | -630,7 | 3,7 |
| Net Margin % | -18,8 | 3,8 |
| Rev Growth 5Y % | 33,1 | 10,0 |
| D/E | 17,2 | 0,2 |
Koersdoel Analisten
Hold
€ 23,33
+98.6%
Low: € 16,00
High: € 27,00
Forward K/W
46,6
Forward WPA
€ 0,26
WPA Groei (sch.)
+0,0%
Omzet Sch.
890 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,59
€ 1,56 – € 1,65
|
1,6 B | 1 |
| FY2029 |
€ 1,20
€ 1,18 – € 1,24
|
1,4 B | 1 |
| FY2028 |
€ 0,81
-€ 0,03 – € 1,64
|
1,2 B | 2 |
Belangrijkste Punten
Revenue grew 33,14% annually over 5 years — strong growth
Debt/Equity of 17,21 — high leverage
Generating 2,78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,19%
Capital efficient — spends only 5,56% of revenue on capex
Groei
Revenue Growth (5Y)
33,14%
Revenue (1Y)24,95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-630,66%
ROIC-9,39%
Net Margin-18,76%
Op. Margin-10,75%
Veiligheid
Debt / Equity
17,21
Current Ratio2,06
Interest Coverage-3,88
Waardering
P/E Ratio
-12,41
P/B Ratio49,36
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 24,95% | Revenue Growth (3Y) | 25,88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33,14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 764,16M | Net Income (TTM) | -143,36M |
| ROE | -630,66% | ROA | -18,12% |
| Gross Margin | 69,60% | Operating Margin | -10,75% |
| Net Margin | -18,76% | Free Cash Flow (TTM) | 2,78M |
| ROIC | -9,39% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 17,21 | Current Ratio | 2,06 |
| Interest Coverage | -3,88 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -12,41 | P/B Ratio | 49,36 |
| P/S Ratio | 2,33 | PEG Ratio | 1,46 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,78B | Enterprise Value | 2,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 764,16M | 611,56M | 482,26M | 350,87M | 243,21M |
| Net Income | -143,36M | -162,12M | -186,64M | -151,29M | -143,03M |
| EPS (Diluted) | -0,96 | -1,13 | -1,54 | -1,47 | -1,50 |
| Gross Profit | 531,89M | 424,26M | 310,20M | 233,06M | 157,76M |
| Operating Income | -82,13M | -136,17M | -173,40M | -146,98M | -128,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 791,21M | 775,71M | 805,21M | 520,97M | 572,05M |
| Total Liabilities | 755,18M | 766,28M | 703,49M | 555,64M | 492,63M |
| Shareholders' Equity | 36,03M | 9,43M | 101,72M | -34,67M | 79,42M |
| Total Debt | 619,95M | 609,94M | 541,68M | 395,86M | 355,43M |
| Cash & Equivalents | 160,81M | 138,84M | 220,97M | 84,70M | 187,25M |
| Current Assets | 450,88M | 417,40M | 451,09M | 255,63M | 331,16M |
| Current Liabilities | 219,18M | 153,03M | 157,57M | 138,87M | 101,10M |